|
department shall report its progress in obtaining the waiver to the | Joint Standing Committee on Appropriations and Financial Affairs | and the Joint Standing Committee on Health and Human Services no | later than October 1, 1998. The department shall submit | legislation to provide coverage under this section prior to | providing such coverage. |
|
| | Sec. 4. 36 MRSA §6162-A, sub-§2, as amended by PL 1997, c. 643, Pt. | RR, §6, is further amended to read: |
|
| | 2. Income. Eligibility for this program is determined by the | same income levels as eligibility for elderly households is | determined under chapter 907, except that individuals are also | eligible for this program if the household spends at least 40% of | its income on unreimbursed direct medical expenses for | prescription drugs and the household income is not more than 25% | higher than the levels specified in chapter 907 according to | Title 22, section 254, subsection 2. For the purposes of this | subsection, the costs of drugs provided to a household under this | chapter is considered a cost spent by the household for | eligibility determination purposes. |
|
| | Sec. 5. 36 MRSA §6162-A, sub-§6, as enacted by PL 1987, c. 528, §2, is | repealed. |
|
| | This bill expands eligibility for the elderly low-cost drug | program to 300%, with persons above 185% paying increased co- | payments on a sliding scale of the federal poverty line. It | preserves the provisions that allow eligibility to be determined | in part on the cost of prescription drugs. It expands the | prescription drugs available under the program to the same | prescription drugs that are offered under the Medicaid program. | It also adds eligibility for disabled persons to the Medicaid | waiver application for a Medicaid prescription drug program. |
|
|